Based on the aggregated intelligence of 140,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, orthopedics giant Stryker (NYSE:SYK) has earned a coveted five-star ranking.

With that in mind, let's take a closer look at Stryker's business and see what CAPS investors are saying about the stock right now.

Stryker facts

Headquarters (Founded)

Kalamazoo, Mich. (1941)

Market Cap

$19.6 billion


Health care equipment and supplies

Trailing-12-Month Revenue

$6.6 billion


CEO Stephen MacMillan (since January 2005)
CFO Curt Hartman (since April 2009)

Return on Equity (Average, Past 3 Years)



$2.93 billion / $0

Other Highly Rated Medical Device Stocks

Intuitive Surgical (NASDAQ:ISRG)
Johnson & Johnson (NYSE:JNJ)
Medtronic (NYSE:MDT)

CAPS Members Bullish on SYK Also Bullish on


CAPS Members Bearish on SYK Also Bearish on

Microsoft (NASDAQ:MSFT)

Sources: Capital IQ (a division of Standard & Poor's) and Motley Fool CAPS.

On CAPS, 97.4% of the 1,355 members who have rated Stryker believe the stock will outperform the S&P 500 going forward, including FinanceGuy58 and Zaya101.

Just a couple of months ago, Stryker struck a chord with FinanceGuy58:

Big cap orthopedic/medical surgery company that got hammered in the downturn. ... As people turn 60 those hips and knees get squeeky. Demographic trends highly favor the orthopedic business. ... The stock has performed historically due to management's never ending focus on financial results.

In a pitch from two weeks earlier, Zaya101 also tapped Stryker as a solid bet to strike back:

This is certainly one of the toughest years for [Stryker]; as with most other med device companies. Yet with their balance sheet, their commitment to their customers and patients, and their high ethical standards, they have used this down year to look internally and vastly improve their compliance and quality processes. ... Once through this learning curve, they'll be a stronger, more adaptable, and more focused company as the global economies begin to recover. And they'll be out in the front of the pack, fundamentally stronger than before.

What do you think about Stryker, or any other stock for that matter? Make your voice heard on Motley Fool CAPS today. The CAPS community is waiting to hear your opinions. CAPS is 100% free, so get started!

Fool contributor Brian Pacampara owns no position in any of the companies mentioned. Stryker and Microsoft are Motley Fool Inside Value picks. Intuitive Surgical and Google are recommendations of Rule Breakers, Johnson & Johnson is an Income Investor choice, and Apple is a Stock Advisor pick. The Fool owns shares of both Stryker and Medtronic. The Fool's disclosure policy always gets a perfect score.